Jonathan Allan sold $17K of STOK stock

Jonathan Allan, General Counsel & Corp Sec of Stoke Therapeutics, Inc. (STOK), sold 627 shares of STOK stock worth $17K, per an SEC Form 4 filed Oct 2, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade was reported on Oct 2, 2026.

STOK has moved +2.3% since the trade date, from $25.62 to $26.20 (Nov 12, 2026 close).